AUG 17, 2016 5:48 PM PDT

How Can We Improve Vaccines Based on Natural Immune Trends?

WRITTEN BY: Kara Marker
Some cells in the immune system are for constantly pumping out antibodies during an infection, while others are saved for later should the same pathogen strike again. In a new study from the Emory Vaccine Center and Stanford’s Department of Pathology, scientists investigated how the immune system differentiates between the two types of cells, in order to adapt a similar process to the development of more effective vaccines. 
Presence of lymphocytes as an infection progresses
Plasmablasts are responsible for immediate antibody production when a pathogen invades the body. Activated B cells, the immune cells that precede memory B cells, don’t secrete antibodies spontaneously like plasmablasts do. However, they can be stimulated to secrete different antibodies according to the content of their DNA. In their recent study published in the journal Nature Immunology, researchers tracked the path of B cells during an immune response by following their DNA patterns.

The team of scientists studied the activity of activated B cells after influenza vaccination, after influenza infection, and during Ebola virus infection. Why Ebola? “Ebola virus infection represents a situation when the patients’ bodies were encountering something they’ve never seen before,” said lead author Ali Ellebedy, PhD. “In contrast, during both influenza vaccination and infection, the immune system generally is relying on recall.”

One week after study participants were immunized for influenza, both flu-specific plasmablasts and flu-specific activated B cells were detected in their blood. However, two weeks after the immunization, the plasmablasts had completely disappeared from the blood, while the activated B cell cells were still proliferating. 

Months after the immunization, activated B cells had completed the transition into resting memory B cells, giving scientists the full picture of how memory cells are produced.

Additionally, they saw a similar trend in Ebola patients with a progressing infection: as the plasmablast count decreased in the blood, the activated B cell count increased. 

With more insight into how antibody-producing cells diminish over time, researchers might make some changes to the way vaccines are created.

“It is still worthwhile to encourage the immune system to make a greater quantity of antibodies, even if their quality does not rise appreciably, and the value of vaccination may be greater when the flu vaccine strains are not identical to those used in previous seasons’ vaccines,” Ellebedy said.
 


Source: Emory Health Sciences
Image: Blood Journal
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
FEB 01, 2021
Microbiology
A Potential Leptospirosis Vaccine is Created
FEB 01, 2021
A Potential Leptospirosis Vaccine is Created
Spirochetes are a type of free-living, spiral-shaped bacteria, some of which are harmless and others that can cause dise ...
FEB 10, 2021
Drug Discovery & Development
Genetics Affect Response to Cancer Immunotherapy
FEB 10, 2021
Genetics Affect Response to Cancer Immunotherapy
Researchers have found that genetic factors may dictate as much as 20% of the efficacy of checkpoint inhibitors, a kind ...
FEB 10, 2021
Immunology
Cross-Reactive Antibodies Don't Protect Against COVID
FEB 10, 2021
Cross-Reactive Antibodies Don't Protect Against COVID
Did you know that hundreds of viruses can cause the common cold? Rhinovirus, adenovirus, and coronavirus infections can ...
MAR 04, 2021
Infographics
All You Need to Know about COVID-19 Vaccines
MAR 04, 2021
All You Need to Know about COVID-19 Vaccines
After over a year lockdowns brought on by the pandemic, hopes for returning to something even similar to ' ...
APR 05, 2021
Cancer
Introducing DeepTCR, the deep-learning software for T-cell receptor sequencing data
APR 05, 2021
Introducing DeepTCR, the deep-learning software for T-cell receptor sequencing data
A team from the Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center is introdu ...
APR 27, 2021
Neuroscience
Leaky Blood-Brain Barrier Linked to Schizophrenia
APR 27, 2021
Leaky Blood-Brain Barrier Linked to Schizophrenia
Researchers from the University of Pennsylvania have found that people with schizophrenia may have a more permeable bloo ...
Loading Comments...